Regencell Bioscience Holdings Limited (RGC)
NASDAQ: RGC · Real-Time Price · USD
27.23
+2.16 (8.62%)
At close: Feb 6, 2026, 4:00 PM EST
27.64
+0.41 (1.51%)
After-hours: Feb 6, 2026, 7:57 PM EST

RGC Balance Sheet

Millions USD. Fiscal year is Jul - Jun.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Cash & Equivalents
2.422.961.566.420.06
Short-Term Investments
2.4851010-
Cash & Short-Term Investments
4.97.9611.5616.420.06
Cash Growth
-38.49%-31.16%-29.56%27532.00%-84.65%
Prepaid Expenses
0.010.150.060.030.01
Total Current Assets
4.98.1111.6216.440.07
Property, Plant & Equipment
0.760.230.891.460.08
Long-Term Deferred Charges
----0.17
Other Long-Term Assets
0.090.10.110.110.02
Total Assets
5.768.4412.6218.020.34
Accrued Expenses
0.350.130.160.150.57
Short-Term Debt
----3.68
Current Portion of Leases
0.310.060.440.41-
Other Current Liabilities
00.010.010.020.08
Total Current Liabilities
0.660.190.610.584.34
Long-Term Leases
0.230.030.030.36-
Total Liabilities
0.90.220.630.944.34
Common Stock
00000
Additional Paid-In Capital
30.1229.8829.4328.510
Retained Earnings
-25.2-21.62-17.32-11.44-4
Comprehensive Income & Other
-0.06-0.05-0.09--
Total Common Equity
4.868.2212.0317.07-4
Minority Interest
---0.040.02-
Shareholders' Equity
4.868.2211.9917.08-4
Total Liabilities & Equity
5.768.4412.6218.020.34
Total Debt
0.540.090.460.773.68
Net Cash (Debt)
4.357.8811.115.65-3.62
Net Cash Growth
-44.73%-29.06%-29.05%--
Net Cash Per Share
0.010.020.020.03-0.01
Filing Date Shares Outstanding
494.49494.49494.49494.49380
Total Common Shares Outstanding
494.49494.49494.49494.49380
Working Capital
4.247.9211.0115.87-4.27
Book Value Per Share
0.010.020.020.03-0.01
Tangible Book Value
4.868.2212.0317.07-4
Tangible Book Value Per Share
0.010.020.020.03-0.01
Machinery
0.450.30.30.3-
Leasehold Improvements
0.620.620.620.60.12
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q